David Cloutier

David Cloutier has extensive work experience in finance, holding various roles in different companies. David started their career as a Tax Senior at Baker Newman Noyes in 2009. David then joined Fresenius Medical Care North America in 2012 as a Manager Financial Planning & Analysis. In 2017, they became an Associate Director FP&A at Boston Biomedical, Inc. David later moved to Boston Pharmaceuticals, where they held roles as Director of Finance and then as Sr. Director of Finance. Currently, David is the Sr. Director of Finance at Nimbus Therapeutics, a position they have held since 2021.

David Cloutier completed their education at the following institutions:

From 2005 to 2009, they attended the UNH Peter T. Paul College of Business and Economics, where they obtained a Bachelor of Science degree in Business Administration. During their time there, they pursued a dual concentration in Accounting and Finance.

In 2014, they enrolled in the Babson F.W. Olin Graduate School of Business. David completed their studies in 2017 and earned a Master of Business Administration (MBA) degree. The specific field of study for their MBA is not mentioned.

In addition to their formal education, David Cloutier has also obtained several certifications. David holds a CFA Level 1 certification from the CFA Institute and is a Certified Public Accountant in the state of New Hampshire. Details about when they obtained these certifications are not provided.